{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:41:13Z","timestamp":1781710873402,"version":"3.54.5"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Sepsis is a systemic inflammatory response syndrome characterized by an inflammatory cytokine storm and immune dysregulation. The clinical benefits of dexmedetomidine in patients with sepsis remain unclear. This study aimed to explore the effects of dexmedetomidine on the inflammatory status and clinical outcomes of patients with sepsis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study searched PubMed, Embase, and the Cochrane Library for records from the setup day of each database up to August 1, 2025. The search strategy was as follows: (Dexmedetomidine OR Dexmedetomidine Hydrochloride OR Precedex OR Igami) AND (Sepsis OR Bloodstream Infection OR Bloodstream Infections OR Septicemia OR Septicemias). The primary outcomes included interleukin-6 (IL-6), tumor necrosis factor-<jats:italic>\u03b1<\/jats:italic> (TNF-\u03b1), and C-reactive protein (CRP). The secondary outcome measures included in-hospital mortality, ICU mortality, 28-day mortality, length of ICU stay, ventilator-free days at day 28, Sequential Organ Failure Assessment (SOFA) score, and Acute Physiology and Chronic Health Evaluation II (APACHE II) score. Stata 14.0 was used for data analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1,550 sepsis patients were included in this study, among whom 759 received dexmedetomidine treatment. Regarding inflammatory factors, the analysis results showed that dexmedetomidine significantly reduced interleukin-6 (IL-6) [standardized mean difference (SMD)\u202f=\u202f0.04, 95% confidence interval (95%CI)\u202f=\u202f(\u22120.11, 0.19), <jats:italic>p<\/jats:italic>\u202f=\u202f0.574] and tumor necrosis factor-<jats:italic>\u03b1<\/jats:italic> (TNF-\u03b1) levels [SMD\u202f=\u202f\u22122.39, 95, 95%CI\u202f=\u202f(\u22123.52, \u22121.27), <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001] in sepsis patients, while exerting no effect on C-reactive protein (CRP) levels. In terms of clinical prognosis, the analysis indicated that dexmedetomidine significantly decreased hospital mortality [relative risk (RR)\u202f=\u202f0.65, 95% confidence interval (95%CI)\u202f=\u202f(0.45, 0.94), <jats:italic>p<\/jats:italic>\u202f=\u202f0.021] and 28-day mortality [RR\u202f=\u202f0.68, 95%CI\u202f=\u202f(0.55, 0.84), <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001] in sepsis patients, with no impact on other secondary outcome measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Dexmedetomidine can reduce the levels of IL-6 and TNF-\u03b1in patients with sepsis, while also decreasing in-hospital mortality and 28-day mortality. Furthermore, early identification of sepsis and subsequent administration of dexmedetomidine for sedation and anti-inflammatory therapy may yield more pronounced clinical benefits.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1695924","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:36:35Z","timestamp":1761024995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Dexmedetomidine reduces the inflammation level and morality in adult sepsis: a systemic review and meta-analysis based on randomized controlled trials"],"prefix":"10.3389","volume":"12","author":[{"given":"Biao","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuepei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiting","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ajem.2025.01.055","article-title":"Emergency medicine updates: evaluation and diagnosis of sepsis and septic shock","volume":"90","author":"Long","year":"2025","journal-title":"Am J Emerg Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/CCM.0000000000004224","article-title":"Sepsis among Medicare beneficiaries: 1. The burdens of Sepsis, 2012-2018","volume":"48","author":"Buchman","year":"2020","journal-title":"Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/00000542-200302000-00024","article-title":"The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects","volume":"98","author":"Nelson","year":"2003","journal-title":"Anesthesiology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s40265-015-0419-5","article-title":"Dexmedetomidine: a review of its use for sedation in the intensive care setting","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"118209","DOI":"10.1016\/j.biopha.2025.118209","article-title":"Dexmedetomidine for the treatment of sepsis-associated encephalopathy: mechanism and prospects","volume":"188","author":"Liu","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3892\/mmr.2022.12889","article-title":"Dexmedetomidine attenuates airway inflammation and oxidative stress in asthma via the Nrf2 signaling pathway","volume":"27","author":"Xiao","year":"2023","journal-title":"Mol Med Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.bja.2019.07.027","article-title":"Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis","volume":"123","author":"Wang","year":"2019","journal-title":"Br J Anaesth"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"7770","DOI":"10.3390\/ijms25147770","article-title":"From molecular mechanisms to clinical therapy: understanding Sepsis-induced multiple organ dysfunction","volume":"25","author":"Srdi\u0107","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.7150\/ijbs.87646","article-title":"Pyroptotic macrophage-derived microvesicles accelerate formation of neutrophil extracellular traps via GSDMD-N-expressing mitochondrial transfer during sepsis","volume":"20","author":"Kuang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7150\/ijbs.86424","article-title":"ADAR1 protects pulmonary macrophages from sepsis-induced pyroptosis and lung injury through miR-21\/A20 signaling","volume":"20","author":"Zhao","year":"2024","journal-title":"Int J Biol Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.7150\/ijbs.84613","article-title":"VDAC2 malonylation participates in sepsis-induced myocardial dysfunction via mitochondrial-related ferroptosis","volume":"19","author":"She","year":"2023","journal-title":"Int J Biol Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e2307216","DOI":"10.1002\/advs.202307216","article-title":"Histone H3K18 and Ezrin Lactylation promote renal dysfunction in Sepsis-associated acute kidney injury","volume":"11","author":"Qiao","year":"2024","journal-title":"Adv Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/0-387-34574-4_12","article-title":"Delirium in septic patients: an unrecognized vital organ dysfunction","volume-title":"Sepsis","author":"Girard","year":"2006"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e1377","DOI":"10.1097\/CCM.0000000000006655","article-title":"Adjunctive sedation with dexmedetomidine for the prevention of severe inflammation and septic encephalopathy: a pilot randomized controlled study","volume":"53","author":"Iten","year":"2025","journal-title":"Crit Care Med."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jclinane.2017.04.003","article-title":"The protective effects of dexmedetomidine on ischemic brain injury: a meta-analysis","volume":"40","author":"Jiang","year":"2017","journal-title":"J Clin Anesth."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e2205097","DOI":"10.1002\/advs.202205097","article-title":"A zinc- and calcium-rich lysosomal Nanoreactor rescues monocyte\/macrophage dysfunction under Sepsis","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv Sci."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e04101","DOI":"10.1002\/advs.202504101","article-title":"BCG-derived outer membrane vesicles induce TLR2-dependent trained immunity to protect against Polymicrobial Sepsis","author":"Gong","year":"2025","journal-title":"Adv Sci."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5498\/wjp.v14.i3.370","article-title":"Brain protective effect of dexmedetomidine vs propofol for sedation during prolonged mechanical ventilation in non-brain injured patients","volume":"14","author":"Yuan","year":"2024","journal-title":"World J Psychiatry."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e884","DOI":"10.1097\/CCM.0000000000006608","article-title":"Dexmedetomidine to reduce vasopressor resistance in Refractory septic shock: \u03b12 agonist Dexmedetomidine for REfractory septic shock (ADRESS): a double-blind randomized controlled pilot trial","volume":"53","author":"Dargent","year":"2025","journal-title":"Crit Care Med."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40560-019-0415-z","article-title":"Dexmedetomidine improved renal function in patients with severe sepsis: an exploratory analysis of a randomized controlled trial","volume":"8","author":"Nakashima","year":"2020","journal-title":"J Intensive Care."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.amjmed.2007.01.035","article-title":"Sepsis","volume":"120","author":"O\u2019Brien","year":"2007","journal-title":"Am J Med."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/imr.12499","article-title":"The immune system\u2019s role in sepsis progression, resolution, and long-term outcome","volume":"274","author":"Delano","year":"2016","journal-title":"Immunol Rev."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4161\/viru.26516","article-title":"The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?","volume":"5","author":"Boomer","year":"2014","journal-title":"Virulence."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J Pathol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cyto.2018.08.015","article-title":"The role of TNF-\u03b1 superfamily members in immunopathogenesis of sepsis","volume":"111","author":"Lendak","year":"2018","journal-title":"Cytokine."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"11238","DOI":"10.3390\/ijms252011238","article-title":"Secondary dengue infection elicits earlier elevations in IL-6 and IL-10 levels","volume":"25","author":"Espindola","year":"2024","journal-title":"Int J Mol Sci."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/978-3-031-59815-9_37","article-title":"IL-6 Blockade in Cytokine Storm Syndromes","volume":"1448","author":"Barrett","year":"2024","journal-title":"Adv Exp Med Biol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00075198-200108000-00002","article-title":"Dexmedetomidine","volume":"7","author":"Coursin","year":"2001","journal-title":"Curr Opin Crit Care."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"122949","DOI":"10.1016\/j.lfs.2024.122949","article-title":"Fighting ferroptosis: protective effects of dexmedetomidine on vital organ injuries","volume":"354","author":"Tian","year":"2024","journal-title":"Life Sci."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e2409499","DOI":"10.1002\/advs.202409499","article-title":"Dexmedetomidine ameliorates myocardial ischemia-reperfusion injury by inhibiting MDH2 Lactylation via regulating metabolic reprogramming","volume":"11","author":"She","year":"2024","journal-title":"Adv Sci."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2327143","DOI":"10.1080\/2162402X.2024.2327143","article-title":"Trial watch: dexmedetomidine in cancer therapy","volume":"13","author":"Carnet Le Provost","year":"2024","journal-title":"Onco Targets Ther."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1177\/08971900221110159","article-title":"Adverse hemodynamic effects of dexmedetomidine in critically ill elderly adults","volume":"36","author":"Ingebrigtson","year":"2023","journal-title":"J Pharm Pract."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1097\/MJT.0000000000001383","article-title":"Dexmedetomidine-associated hypernatremia and polyuria","volume":"29","author":"Singh","year":"2022","journal-title":"Am J Ther."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.chest.2024.06.3794","article-title":"Dexmedetomidine for reducing mortality in patients with septic shock: a randomized controlled trial (DecatSepsis)","volume":"166","author":"Ezz Al-Regal","year":"2024","journal-title":"Chest."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3760\/cma.j.issn.2095-4352.2018.02.011","article-title":"Effect and mechanism of dexmedetomidine on lungs in patients of sepsis complicated with acute respiratory distress syndrome","volume":"30","author":"Chen","year":"2018","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1056\/NEJMoa2024922","article-title":"Dexmedetomidine or Propofol for sedation in mechanically ventilated adults with Sepsis","volume":"384","author":"Hughes","year":"2021","journal-title":"N Engl J Med."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s13054-022-04237-0","article-title":"Stress response during early sedation with dexmedetomidine compared with usual-care in ventilated critically ill patients","volume":"26","author":"Moore","year":"2022","journal-title":"Crit Care."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/SHK.0000000000001055","article-title":"Effect of Dexmedetomidine on lactate clearance in patients with septic shock: a subanalysis of a multicenter randomized controlled trial","volume":"50","author":"Miyamoto","year":"2018","journal-title":"Shock."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM consensus conference committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"America: Chest."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.clinthera.2024.11.004","article-title":"The effect of dexmedetomidine on inflammatory factors and clinical outcomes in patients with septic shock: a randomized clinical trial","volume":"47","author":"Mokhlesian","year":"2025","journal-title":"Clin Ther."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/11101849.2022.2109826","article-title":"Effect of dexmedetomidine vs midazolam on the microcirculation of septic patients who are mechanically ventilated","volume":"38","author":"Mohamed","year":"2022","journal-title":"Egypt J Anaesth."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jclinane.2008.10.010","article-title":"Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis","volume":"21","author":"Tasdogan","year":"2009","journal-title":"J Clin Anesth."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1186\/cc8916","article-title":"Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial","volume":"14","author":"Pandharipande","year":"2010","journal-title":"Crit Care."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1001\/jama.2017.2088","article-title":"Effect of Dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with Sepsis: a randomized clinical trial","volume":"317","author":"Kawazoe","year":"2017","journal-title":"JAMA."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1695924\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:36:36Z","timestamp":1761024996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1695924\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":50,"alternative-id":["10.3389\/fmed.2025.1695924"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1695924","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"article-number":"1695924"}}